(Q38836420)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26355643%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

title

Circulating tumor cells are correlated with disease progression and treatment response in an orthotopic hepatocellular carcinoma model (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26355643%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

main subject

hepatocellular carcinoma

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26355643%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

author name string

Jun Yan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26355643%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Xiufeng Wu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26355643%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Min Xu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26355643%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Jiahao Jiang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26355643%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Changjun Tan

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26355643%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Weizhong Wu

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26355643%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Xunbin Wei

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26355643%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Jian Zhou

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26355643%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

language of work or name

1 reference

10 September 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26355643%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26355643%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

volume

87

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26355643%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26355643%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

page(s)

1020-1028

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26355643%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22782

Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22782

Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22782

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22782

Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22782

In vivo flow cytometer for real-time detection and quantification of circulating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22782

In vivo flow cytometry: a new method for enumerating circulating cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22782

In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22782

Circulation times of prostate cancer and hepatocellular carcinoma cells by in vivo flow cytometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22782

Real-time monitoring of rare circulating hepatocellular carcinoma cells in an orthotopic model by in vivo flow cytometry assesses resection on metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22782

Systematic review: evidence-based management of hepatocellular carcinoma--an updated analysis of randomized controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22782

Updated treatment approach to hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22782

Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22782

Sorafenib in advanced hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22782

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22782

BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22782

New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22782

A reproducible rat liver cancer model for experimental therapy: introducing a technique of intrahepatic tumor implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22782

Prospective evaluation of circulating hepatocytes by alpha-fetoprotein messenger RNA in patients with hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22782

alpha-Fetoprotein mRNA in the circulation as a predictor of postsurgical recurrence of hepatocellular carcinoma: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22782

Alpha-fetoprotein and human telomerase reverse transcriptase mRNA levels in peripheral blood of patients with hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22782

Detecting AFP mRNA in peripheral blood of the patients with hepatocellular carcinoma, liver cirrhosis and hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22782

Association between recurrence of hepatocellular carcinoma and alpha-fetoprotein messenger RNA levels in peripheral blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22782

Albumin mRNA in plasma predicts post-transplant recurrence of patients with hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22782

Isolation of circulating tumor cells in patients with hepatocellular carcinoma using a novel cell separation strategy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22782

Prediction of posthepatectomy recurrence of hepatocellular carcinoma by circulating cancer stem cells: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22782

7 January 2021

Prospective evaluation of circulating hepatocytes by alpha-fetoprotein mRNA in humans during liver surgery

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22782

7 January 2021

Hematogenous spreading of hepatocellular carcinoma cells: possible participation in recurrence in the liver

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22782

7 January 2021

Real-time quantification of AFP mRNA to assess hematogenous dissemination after transarterial chemoembolization of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22782

7 January 2021

Perioperative change in albumin messenger RNA levels in patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22782

7 January 2021

Lack of specificity of albumin-mRNA-positive cells as a marker of circulating hepatoma cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22782

7 January 2021

Characteristics of hepatic igf-ii expression and monitored levels of circulating igf-ii mRNA in metastasis of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22782

7 January 2021

High expression of Snail mRNA in blood from hepatocellular carcinoma patients with extra-hepatic metastasis

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22782

7 January 2021